Leukoencephalopathy With Vanishing White Matter 4 C5830406
A rare inherited condition where brain white matter gradually deteriorates and appears to vanish on scans. It primarily affects children and causes progressive neurological decline. Treatment involves supportive measures and avoiding stress to the nervous system.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Progressive cerebellar ataxia
(neurologic)Spasticity
(neurologic)Cognitive decline
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Stress and Infection Avoidance Protocol
Strict avoidance of physical and emotional stressors including infections, head trauma, and extreme temperatures, which can trigger acute neurological deterioration in vanishing white matter disease.
Seizure Control Therapy
Antiepileptic medication tailored to seizure type, recognizing that seizure management is often challenging in vanishing white matter disease and may require combination therapy.
Additional treatment options
Adapted Physical Therapy Program
Therapeutic exercises focusing on balance, gait training, and maintaining range of motion while avoiding fatigue. Therapy intensity must be carefully monitored to prevent overstressing the vulnerable white matter.
physical_therapyNeuroimaging Surveillance
Serial MRI studies to document progressive white matter rarefaction and replacement by cerebrospinal fluid, guiding prognostic discussions and care planning.
monitoringFamily Counseling and Support
Psychological support for patients and families dealing with progressive neurodegenerative disease, including grief counseling, anticipatory guidance, and connection to support networks.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Leukoencephalopathy With Vanishing White Matter 4 C5830406?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Leukoencephalopathy With Vanishing White Matter 4 C5830406. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy